Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel photocatalytic trifluoromethylation of aniline drugs improves anticancer activity. Efficient, mild synthesis for reliable pharmaceutical intermediate supply.
Patent CN118772160A reveals a visible-light photocatalytic synthesis for trifluoromethyl dihydropyrroloquinazolinones, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110483345A enables green selective oxidation of thioethers. Discover cost-effective pharmaceutical intermediate manufacturing with mild visible light conditions.
Novel visible light catalytic synthesis method offers mild conditions and environmental safety for high-purity pharmaceutical intermediates manufacturing supply chain.
Patent CN107983349B reveals a visible light catalyst for 1,3-butadiyne synthesis offering green manufacturing and supply chain efficiency for pharmaceutical intermediates.
Patent CN107141248A enables visible light synthesis of 3-sulfonyl spirotrienones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113072460B details a metal-free visible light method for morpholine oxidative ring-opening, offering cost reduction and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN112812060A reveals metal-free arylation. Offers green synthesis for high-purity pharmaceutical intermediates with simplified supply chains.
Novel visible-light method for 1,2-allenyl ketones offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply chains.
Patent CN110183394B reveals a mild photocatalytic route for 3-nitrile ethyl-2-hydrocarbyl-4H-benzoxazine, offering safer cyanation and scalable manufacturing for global supply chains.
Patent CN110183394B details a mild photocatalytic route for 3-nitrile ethyl-2-hydrocarbyl-4H-benzoxazine, offering cost-effective API intermediate manufacturing.
Patent CN115057794B enables visible light-induced demethylation. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN108586283B reveals a green visible-light method using Rose Bengal, eliminating metal oxidants for safer pharmaceutical intermediate manufacturing.
Patent CN119431386A reveals photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable green chemistry processes.
Visible light photocatalysis method for beta-methoxy fatty acid esters. Metal-free, green process offering supply chain stability and cost efficiency for fine chemical manufacturing.
Patent CN111269228A reveals a green photocatalytic route for fluorescent indolizine derivatives, offering cost-effective manufacturing for pharma intermediates.
Novel visible-light method for quinoline intermediates. Reduces cost and improves supply chain reliability for anti-tumor drug development.
Patent CN111777477A details a mild visible-light method for synthesizing succinic acid derivatives and 3-arylpropionic acids using CO2, offering significant cost and safety advantages.
Patent CN108083999B details a visible-light catalyzed route for alpha-hydroxy ketones, offering cost reduction and green manufacturing advantages for pharmaceutical intermediates.
Patent CN114805226B reveals metal-free synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.